M C Del Canizo
Overview
Explore the profile of M C Del Canizo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
286
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Del Canizo M, Fisac M, Galende J, Hurtado J, Moro M, Rodriguez J, et al.
Br J Haematol
. 2001 Dec;
115(3):541-4.
PMID: 11736933
Recombinant(R) interferon alpha (r-IFN-alpha) has been shown to be an effective drug for chronic myeloid leukaemia (CML). However, higher response rates can be achieved using cytarabine along with r-IFN-alpha. YNK01...
12.
Menendez P, Del Canizo M, Orfao A
J Biol Regul Homeost Agents
. 2001 Jun;
15(1):53-61.
PMID: 11388745
No abstract available.
13.
Seabra C, Perez-Simon J, Sierra M, Marcos J, Caballero M, De La Loma A, et al.
Bone Marrow Transplant
. 2001 Jan;
26(11):1229-30.
PMID: 11149737
Hemorrhagic cystitis (HC) is a common complication following hemopoietic stem cell transplantation (HSCT), its incidence ranging from 7 to 52% of all patients. Late occurring HC frequently results from viral...
14.
Arroyo J, Gutierrez N, Garcia-Marcos M, Villarroel R, Galindo P, Fernandez M, et al.
Br J Haematol
. 2000 Dec;
111(3):987-9.
PMID: 11122167
No abstract available.
15.
Hernandez R, Del Canizo M, Lopez C, Gonzalez M, Vazquez M, Caballero M, et al.
Med Oncol
. 2000 Dec;
17(4):337-9.
PMID: 11114715
Pathological rupture of the spleen is a rare but well recognized complication in hematological malignancies. Early clinical recognition of this life-threatening complication is necessary for rapid intervention. Here, we report...
16.
Hernandez J, Del Canizo M, Cuneo A, Garcia J, Gutierrez N, Gonzalez M, et al.
Ann Oncol
. 2000 Jun;
11(4):441-4.
PMID: 10847463
Background: Atypical chronic myeloid leukemia (aCML) is an infrequent chronic myeloproliferative disorder characterized by leukocytosis, absence of Philadelphia chromosome or BCR-ABL rearrangement, and marked myeloid dysplasia. Some cases have an...
17.
Amigo M, Del Canizo M, Caballero M, Vazquez L, Corral M, Vidriales B, et al.
Bone Marrow Transplant
. 1999 Aug;
24(3):289-93.
PMID: 10455368
The aim of the present study was to assess which factors influence hematopoietic function long term after transplantation. For this purpose, we have analyzed a series of 79 patients who...
18.
Amigo M, Del Canizo M, Rios A, Garcia M, Caballero M, Martin A, et al.
Bone Marrow Transplant
. 1999 Jun;
23(10):997-1002.
PMID: 10373064
Secondary myelodysplastic syndromes (MDS) are increasingly being reported after autologous transplantation. Transient dysplastic changes have also been observed after this type of treatment. However, to the best of our knowledge...
19.
Del Canizo M, Lopez N, Vazquez L, Fernandez M, Ana B, Caballero M, et al.
Haematologica
. 1999 Jun;
84(6):511-6.
PMID: 10366794
Background And Objective: Patients with malignancies receive chemotherapy to induce tumor remission which could damage hematopoiesis and adversely influence hematopoietic reconstitution after transplantation. In the present study we used a...
20.
Ciudad J, San Miguel J, Lopez-Berges M, Garcia Marcos M, Gonzalez M, Vazquez L, et al.
Br J Haematol
. 1999 Apr;
104(4):695-705.
PMID: 10192428
Immunophenotypic investigation of minimal residual disease (MRD) has traditionally been based on the investigation of phenotypic aberrants at diagnosis to be used later as a target for MRD detection. This...